🇺🇸 FDA
Patent

US 6867190

Methods of therapy with thrombin derived peptides

expired A61KA61K38/4833A61K9/1647

Quick answer

US patent 6867190 (Methods of therapy with thrombin derived peptides) held by The Board of Regents of the University of Texas System expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K38/4833, A61K9/1647, A61P, A61P43/00